| A placebo-controlled trial of obeticholic acid in primary biliary cholangitis F Nevens, P Andreone, G Mazzella, SI Strasser, C Bowlus, P Invernizzi, ... New England Journal of Medicine 375 (7), 631-643, 2016 | 1121 | 2016 |
| EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis GM Hirschfield, U Beuers, C Corpechot, P Invernizzi, D Jones, M Marzioni, ... Journal of hepatology 67 (1), 145-172, 2017 | 1007 | 2017 |
| Natural history of early primary biliary cirrhosis JV Metcalf, HC Mitchison, JM Palmer, DE Jones, MF Bassendine, ... The Lancet 348 (9039), 1399-1402, 1996 | 567 | 1996 |
| Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis GF Mells, JAB Floyd, KI Morley, HJ Cordell, CS Franklin, SY Shin, ... Nature genetics 43 (4), 329-332, 2011 | 537 | 2011 |
| Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’ U Beuers, EM Gershwin, RG Gish, P Invernizzi, DEJ Jones, K Lindor, ... Official journal of the American College of Gastroenterology| ACG 110 (11 …, 2015 | 456 | 2015 |
| Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid M Carbone, GF Mells, G Pells, MF Dawwas, JL Newton, MA Heneghan, ... Gastroenterology 144 (3), 560-569. e7, 2013 | 434 | 2013 |
| Primary sclerosing cholangitis JK Dyson, U Beuers, DEJ Jones, AW Lohse, M Hudson The Lancet 391 (10139), 2547-2559, 2018 | 412 | 2018 |
| The UK‐PBC risk scores: derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis M Carbone, SJ Sharp, S Flack, D Paximadas, K Spiess, C Adgey, ... Hepatology 63 (3), 930-950, 2016 | 380 | 2016 |
| The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines GM Hirschfield, JK Dyson, GJM Alexander, MH Chapman, J Collier, ... Gut 67 (9), 1568-1594, 2018 | 349 | 2018 |
| International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways HJ Cordell, Y Han, GF Mells, Y Li, GM Hirschfield, CS Greene, G Xie, ... Nature communications 6 (1), 8019, 2015 | 311 | 2015 |
| Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis JZ Liu, MA Almarri, DJ Gaffney, GF Mells, L Jostins, HJ Cordell, SJ Ducker, ... Nature genetics 44 (10), 1137-1141, 2012 | 308 | 2012 |
| Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease KA Rygiel, H Robertson, HL Marshall, M Pekalski, L Zhao, TA Booth, ... Laboratory investigation 88 (2), 112-123, 2008 | 305 | 2008 |
| Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis K Agarwal, AJ Czaja, DE Jones, PT Donaldson Hepatology 31 (1), 49-53, 2000 | 281 | 2000 |
| A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis KV Kowdley, V Luketic, R Chapman, GM Hirschfield, R Poupon, ... Hepatology 67 (5), 1890-1902, 2018 | 280 | 2018 |
| Alcoholic liver disease: new insights into mechanisms and preventative strategies S Stewart, D Jones, CP Day Trends in molecular medicine 7 (9), 408-413, 2001 | 272 | 2001 |
| Familial primary biliary cirrhosis reassessed: a geographically-based population study DEJ Jones, FE Watt, JV Metcalf, MF Bassendine, OFW James Journal of hepatology 30 (3), 402-407, 1999 | 272 | 1999 |
| Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis MI Prince, AD Burt, DEJ Jones Gut 50 (3), 436-439, 2002 | 267 | 2002 |
| Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis A Jacoby, A Rannard, D Buck, N Bhala, JL Newton, OFW James, ... Gut 54 (11), 1622-1629, 2005 | 265 | 2005 |
| British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis MH Chapman, D Thorburn, GM Hirschfield, GGJ Webster, SM Rushbrook, ... Gut 68 (8), 1356-1378, 2019 | 252 | 2019 |
| Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study FE Watt, OFW James, DEJ Jones Qjm 97 (7), 397-406, 2004 | 243 | 2004 |
